Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Zhihong Chi, Bixia Tang, Xinan Sheng, Lu Si, Chuanliang Cui, Yan Kong, Dan Li, Si Ming Li, Xieqiao Yan, Li Li Mao, Bin Lian, Xue Bai, Xuan Wang, Li Zhou, Jiayi Yu, Mingli Xu, Lihou Dong, Haifeng Song, Jun Guo | ||||||||||||
Title | A phase I study of JS001, a humanized IgG4 mAb against programmed death-1 (PD-1) in patients with advanced solid tumors | ||||||||||||
|
|||||||||||||
URL | http://abstracts.asco.org/199/AbstView_199_189353.html | ||||||||||||
Abstract Text | J Clin Oncol 35, 2017 (suppl; abstr 3067) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|